Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.41% | 73.97 | 0.9% | $407.36m | |
| AMGN | Amgen Inc. | 0.32% | 202.98 | 1.2% | $406.21m | |
| CELG | Celgene Corporation | -0.41% | 87.25 | 1.2% | $335.52m | |
| BIIB | Biogen Inc. | 0.53% | 338.66 | 1.2% | $283.70m | |
| ILMN | Illumina, Inc. | -0.77% | 348.18 | 3.5% | $249.42m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.16% | 383.82 | 2.6% | $210.58m | |
| EXAS | Exact Sciences Corporation | 0.47% | 73.10 | 25.3% | $193.16m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.55% | 176.15 | 1.9% | $159.75m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.39% | 152.98 | 16.4% | $125.90m | |
| A | Agilent Technologies, Inc. | 0.44% | 69.23 | 1.5% | $121.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.55% | 121.48 | 2.0% | $111.46m | |
| VKTX | Viking Therapeutics, Inc. | 6.22% | 20.67 | 0.9% | $94.21m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.43% | 93.35 | 9.7% | $93.70m | |
| NKTR | Nektar Therapeutics | -2.62% | 56.80 | 5.6% | $93.21m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.65% | 98.92 | 4.4% | $93.05m |
Company Profile
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.